Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
Gomis RR, Alarcón C, Nadal C, Van Poznak C, Massagué J. Gomis RR, et al. Among authors: van poznak c. Cancer Cell. 2006 Sep;10(3):203-14. doi: 10.1016/j.ccr.2006.07.019. Cancer Cell. 2006. PMID: 16959612
Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Marcath LA, Kidwell KM, Vangipuram K, Gersch CL, Rae JM, Burness ML, Griggs JJ, Van Poznak C, Hayes DF, Smith EML, Henry NL, Beutler AS, Hertz DL. Marcath LA, et al. Among authors: van poznak c. Br J Clin Pharmacol. 2020 May;86(5):880-890. doi: 10.1111/bcp.14192. Epub 2020 Feb 4. Br J Clin Pharmacol. 2020. PMID: 31823378
Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer.
Barton DL, Brooks TM, Cieslak A, Elkins GR, Clark PM, Baydoun M, Smith AB, Van Poznak CH. Barton DL, et al. Breast Cancer Res Treat. 2019 Nov;178(2):357-365. doi: 10.1007/s10549-019-05395-6. Epub 2019 Aug 9. Breast Cancer Res Treat. 2019. PMID: 31399932 Clinical Trial.
Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.
Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, Edwards BJ, Frank E, Lyman GH, Smith MR, Mhaskar R, Henderson T, Neuner J. Shapiro CL, et al. Among authors: van poznak c. J Clin Oncol. 2019 Nov 1;37(31):2916-2946. doi: 10.1200/JCO.19.01696. Epub 2019 Sep 18. J Clin Oncol. 2019. PMID: 31532726
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.
Van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K, Borgen P, Gollub M, Bacotti D, Yao TJ, Bloch R, Ligueros M, Sonenberg M, Norton L, Hudis C. Van Poznak C, et al. Among authors: van zee k. Breast Cancer Res Treat. 2001 Apr;66(3):239-48. doi: 10.1023/a:1010686204736. Breast Cancer Res Treat. 2001. PMID: 11510695 Clinical Trial.
How are bisphosphonates used today in breast cancer clinical practice?
Van Poznak C. Van Poznak C. Semin Oncol. 2001 Aug;28(4 Suppl 11):69-74. doi: 10.1053/sonc.2001.25445. Semin Oncol. 2001. PMID: 11544580 Review.
Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer.
Van Poznak C, Tan L, Panageas KS, Arroyo CD, Hudis C, Norton L, Seidman AD. Van Poznak C, et al. J Clin Oncol. 2002 May 1;20(9):2319-26. doi: 10.1200/JCO.2002.08.125. J Clin Oncol. 2002. PMID: 11981003
Critical review of current treatment strategies for advanced hormone insensitive breast cancer.
Van Poznak C, Seidman AD. Van Poznak C, et al. Cancer Invest. 2002;20 Suppl 2:1-14. doi: 10.1081/cnv-120014881. Cancer Invest. 2002. PMID: 12442344 Review.
The use of bisphosphonates in patients with breast cancer.
Van Poznak CH. Van Poznak CH. Cancer Control. 2002 Nov-Dec;9(6):480-9. doi: 10.1177/107327480200900605. Cancer Control. 2002. PMID: 12514566 Review.
Clinical management of osteoporosis in women with a history of breast carcinoma.
Van Poznak C, Sauter NP. Van Poznak C, et al. Cancer. 2005 Aug 1;104(3):443-56. doi: 10.1002/cncr.21201. Cancer. 2005. PMID: 15968687 Review.
128 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback